A practical reference on thymosin beta-4: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-04-30. Anything still debated is marked as such rather than presented as settled.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
Lyophilized peptide arrives as a dry cake that should stay sealed until use. Reconstitution is generally performed with sterile water or a buffered solution, and the resulting liquid should be handled gently to limit mechanical stress. Repeated freeze-thaw cycles are widely described as harmful to short peptides, so dividing a reconstituted batch into single-use portions is a common practice. Laboratories also record the solvent, concentration, and date of preparation on the vial label to keep later measurements traceable.
Dry powder is commonly held at minus twenty degrees Celsius, with some suppliers recommending lower temperatures for long-term archival storage. Once dissolved, solutions are typically kept cold and protected from light, since aqueous peptide solutions can lose integrity through hydrolysis or oxidation over time. Stability data specific to this fragment are limited in the public literature, and much of the guidance comes from general peptide handling practice rather than from controlled degradation studies. Users therefore treat stated shelf lives as approximate rather than fixed.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | N-terminal fragment of thymosin beta-4 |
| Residue count | Seven | Sequence LKKTETQ |
| Approximate mass | 889 Da | Acetylated seven-residue peptide |
| Common synonyms | TB4 fragment, TB500 | Not identical to full-length TB4 |
| Reported activity | Actin binding | Observed mainly in cell-free systems |
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
Material is normally supplied as a lyophilised powder in a sealed vial. The powder is hygroscopic, so exposure to humid air leads to water uptake, caking and gradual loss of the fluffy texture that indicates a good freeze-dry. Vials are best kept sealed with desiccant, protected from light and stored cold. Letting a cold vial warm to room temperature before opening reduces condensation on the contents. Purity is normally reported from a chromatographic run, and that figure applies to the batch as tested rather than to the vial after repeated opening.
Once dissolved, the peptide is far less stable than the dry powder. Aqueous solutions are subject to hydrolysis, oxidation at susceptible residues and gradual loss of material through adsorption onto glass and plastic surfaces. Terminal glutamine can cyclise under some conditions, producing a related species that complicates purity assessment. Dilute solutions tend to lose a larger fraction of material to surfaces than concentrated ones. Buffers, pH and ionic strength all influence the rate of change, so stability figures are only meaningful when those parameters are stated alongside the storage interval.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
The fourth-largest cargo airline worldwide, UPS Airlines flies to over 800 destinations worldwide (the most of any airline, cargo or passenger). Formed in 1988, the airline is headquartered in Louisville, Kentucky (home to Worldport, its worldwide air hub) with additional hubs in the United States located in Ontario, California, Dallas, Texas, Rockford, Illinois and Philadelphia. Outside of North America, a hub in Cologne, Germany services Europe; in Asia, UPS Airlines operates a facility in Hong Kong and two hubs in mainland China. Consisting of a fleet of nearly 300 aircraft (as of 2025), the airline competes directly against FedEx Express, facilitating air shipments by the company in over 200 countries and territories worldwide.
Muslims, India's largest religious minority, have contributed significantly to a synthetic Indo-Islamic religious culture. Sufism, the heterodox mystical movement in Islam found receptiveness among adherents of the medieval regional Shaivite and Vaishnavite traditions of Bhakti. Sikh gurdwaras and Sufi dargahs often attract both visitors and worshippers from other religions. India has monastic traditions such as that of Jain ascetics some of whom practice an extreme form of nonviolence (ahimsa) and Buddhist communities that have preserved ancient styles of meditations. This religious diversity coexists with religious endogamy—people rarely marry outside their faith. There is also religious segregation in housing—religious groups cluster by choice or necessity. Thus, India's religious picture has both rich intermixing and clear divisions.
== History == Much of the preparatory work that led into the adoption of RM-ODP as an ISO standard was carried out by the Advanced Networked Systems Architecture (ANSA) project. This ran from 1984 until 1998 under the leadership of Andrew Herbert (now MD of Microsoft Research in Cambridge), and involved a number of major computing and telecommunication companies. Parts 2 and 3 of the RM-ODP were eventually adopted as ISO standards in 1996. Parts 1 and 4 were adopted in 1998.
Sources: en.wikipedia.org
Noradrenergic and serotonergic nuclei in the ARAS are involved in the regulation of the REM sleep cycle and function as "REM-off" cells, with amphetamine's effect on norepinephrine and serotonin contributing to the suppression of REM sleep and a possible reduction of cataplexy at high doses. The American Academy of Sleep Medicine (AASM) 2021 clinical practice guideline conditionally recommends dextroamphetamine for the treatment of both type 1 and type 2 narcolepsy. Treatment with pharmaceutical amphetamines is generally less preferred relative to other stimulants (e.g., modafinil) and is considered a third-line treatment option. Medical reviews indicate that amphetamine is safe and effective for the treatment of narcolepsy. Amphetamine appears to be most effective at improving symptoms associated with hypersomnolence, with three reviews finding clinically significant reductions in daytime sleepiness in patients with narcolepsy. Additionally, these reviews suggest that amphetamine may dose-dependently improve cataplexy symptoms. However, the quality of evidence for these findings is low and is consequently reflected in the AASM's conditional recommendation for dextroamphetamine as a treatment option for narcolepsy.
== Published works == In 2013, Mendes published "Mendes System of Praying Exercises for the Hip Joints", through Kotarim International Publishing. In 2014, he published a new edition, "Mendes System Pain Free Arthritis Exercises", through Kotarim International Publishing. In 2019, Prof. Mendes published through Niv books a Hebrew edition "Who is Afraid of Medical Malpractice? Insights about Medicine and Law" He lights up the little-known world of medical malpractice and uses his experience to lay out five mental attitudes that cause doctors to make mistakes and lead them down a slippery slope. "Diary of Coronavirus family" a book published through Partridge Singapore April 2021 The Coronavirus family, a rowdy group of viruses who use the Human Beings as entertainment and cause them all sorts of trouble, gathers together and reminisces about the past, including various epidemics that they brought about over the course of history, up until the day that the Coronavirus pandemic broke out, leaving the Human Beings confused and helpless. The Coronavirus, whose name is CoV-2, describes how he caused the pandemic while also voicing some harsh criticism regarding the way the Human Beings chose to cope with it. Mama educates the virion, the youngster virus, about the tradition and life cycle of viruses, their genetics and how to grow to adulthood. Her beloved son Cov-2 is the virus involved in the break out of the COVID-19 in Wuhan, and he challenges himself to spread the epidemic to human beings worldwide.
=== Click chemistry === Thionyl tetrafluoride can be used in click chemistry through reactions with primary amines known as sulfur(VI) fluoride exchange (SuFEx). This kind of reaction was the first "click" reaction to generate a three-dimensional core. Reactions with amines will lead to the corresponding sulfurimidoyl difluoride, which has been used in multiple high throughput screening efforts to discover new inhibitors or molecular glue degraders.
Sources: en.wikipedia.org
=== La–Li === Irving Langmuir (1881–1957), American chemist, physicist, 1932 Nobel Prize in Chemistry for work in surface chemistry Auguste Laurent (1807–1853), French chemist who discovered trichloroethylene, anthracene, phthalic acid, and carbolic acid Paul Lauterbur (1929–2007), American chemist, Nobel Prize in Physiology or Medicine (2003) work which that the development of magnetic resonance imaging possible Antoine Lavoisier (1743–1794), French chemist who recognized oxygen and hydrogen as elements Nicolas Leblanc (1742–1806), French chemist and surgeon who discovered how to manufacture soda ash from common salt Henri Louis Le Chatelier (1850–1936), French chemist known for Le Chatelier's principle, which allows prediction of the effect of a changing condition on a system in chemical equilibrium Yuan T. Lee (born 1936), Taiwanese chemist, 1986 Nobel Prize in Chemistry for contributions to the development of reaction dynamics Valery Legasov (1936–1988), Soviet inorganic chemist known for his position as head of the Chernobyl Commission for the Chernobyl Disaster Jean-Marie Lehn (born 1939), French chemist, 1987 Nobel Prize in Chemistry for the synthesis of cryptands Marko Leko (1853–1932), Serbian chemist known for work on the nature of ammonium chloride Luis Federico Leloir (1906–1987), Argentine biochemist and winner of the 1970 Nobel Prize in Chemistry Raymond Lemieux (1920–2000), Canadian organic chemist, Wolf Prize in Chemistry Gilbert Newton Lewis (1875–1946), American chemist and first Dean of the Berkeley College of Chemistry
== Fascia research == In 2007, Schleip along with Werner Klingler organized the first Fascia Research Congress, sponsored by the National Institute of Health and hosted at Harvard Medical School. The conference was covered in a two-page Science Magazine article titled "Cell Biology Meets Rolfing with a section titled "From Rolfer to Researcher" referring to Schleip's career shift. He has served on the scientific committee for all subsequent congresses (2009, 2012, 2015, 2018, 2022, 2025) and chaired the 2018 and 2022 congresses. He was a founding member of the Fascia Research Society in 2011 and has served on the board of directors since 2020. In 2023 he received the designation of founding director. Schleip is the director of the Fascia Research Group, a research collaboration between the University of Ulm (2007-2019) and the Technical University of Munich (2019-Present). He is co-founder and co-director of the Institute für Angewandte & Integrative Gesundheitsforschung (IAIG), a research institute directed towards applied and integrative health research under the umbrella of the Diploma University of Applied Sciences in Germany (2024–present).
== Phases == The course of the action potential can be divided into five parts: the rising phase, the peak phase, the falling phase, the undershoot phase, and the refractory period. During the rising phase the membrane potential depolarizes (becomes more positive). The point at which depolarization stops is called the peak phase. At this stage, the membrane potential reaches a maximum. Subsequent to this, there is a falling phase. During this stage the membrane potential becomes more negative, returning towards resting potential. The undershoot, or afterhyperpolarization, phase is the period during which the membrane potential temporarily becomes more negatively charged than when at rest (hyperpolarized). Finally, the time during which a subsequent action potential is impossible or difficult to fire is called the refractory period, which may overlap with the other phases. The course of the action potential is determined by two coupled effects. First, voltage-sensitive ion channels open and close in response to changes in the membrane voltage Vm. This changes the membrane's permeability to those ions. Second, according to the Goldman equation, this change in permeability changes the equilibrium potential Em, and, thus, the membrane voltage Vm. Thus, the membrane potential affects the permeability, which then further affects the membrane potential. This sets up the possibility for positive feedback, which is a key part of the rising phase of the action potential.
Sources: en.wikipedia.org
No. Thymosin beta-4 is a 43-residue protein, while TB-500 refers to a seven-residue fragment corresponding to its N-terminal region. The two names are often used loosely in commercial and community writing, which obscures the difference in size, sequence, and likely behavior.
The fragment contains an actin-binding motif, and cell-free experiments show that it can interact with monomeric actin. That observation is the basis for interest in cell migration and repair processes. Effects reported in animals are not established for humans.
Purity is usually stated by the supplier rather than fixed by a pharmacopoeial monograph, and typical listings report a percentage from reverse-phase HPLC. Independent verification is uncommon. Because no single accepted specification exists, comparisons between lots and between suppliers are difficult.
Dry lyophilized powder is usually kept frozen, desiccated, and out of direct light. Sealed vials are not opened until needed, because moisture uptake can degrade short peptides. Longer archival storage is often done at lower temperatures than routine working stock.